Main sector:
Pharma (fully integrated)
Subsectors:
Antibodies
Anti-infectives
Biosimilars
Drug delivery
Generics
Proteins
Small molecule therapeutics
Antibody-drug-conjugate
Indications:
Infectious and parasitic diseases / infectiology / parasitology
Neoplasms / cancer / oncology
Diseases of the blood and blood-forming organs & immune disorders / hematology / immunology
Endocrine, nutritional and metabolic diseases / endocrinology
Diseases of the nervous system / neurology
Diseases of the eye / ophthalmology
Cardiovascular / cardiology
Respiratory / pulmonology
Digestive system / gastroenterology
Skin and subcutaneous tissue / dermatology
Musculoskeletal system and connective tissue / Orthopedics
Genitourinary system / Urology
Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
Products
In development: 81
On the market: 20
Description:
Jiangsu Hengrui Medicine Co., Ltd., is a pharmaceutical company which manufactures and distributes pharmaceutical tablets, injections and raw materials. The Company’s main products portfolio consists of antineoplastic drugs, surgery medications, and medicines that treat autoimmune diseases, metabolic diseases and cardiovascular diseases.
